Food and Drug Regulations
Version of section C.01A.019 from 2006-03-22 to 2024-06-16:
C.01A.019 (1) For the purposes of this Division and Divisions 2 to 4, a regulatory authority that is set out in column 1 of the table to this section is hereby designated in respect of the activities set out in column 3 for the drug or category of drugs set out in column 2.
(2) Whole blood and its components are excluded from the drugs and categories of drugs set out in column 2 of the table to this section.
(3) The lot release of drugs listed in Schedule D to the Act is excluded from the activity of testing set out in column 3 of the table to this section.
TABLE
Designated Regulatory Authorities
Item Column 1 Column 2 Column 3 Regulatory authority Drug or category of drugs Activities 1 Swissmedic, Swiss Agency for Therapeutic Products, Bern, Switzerland Pharmaceuticals for human or veterinary use Fabricating, packaging/labelling, testing Drugs listed in Schedules C and D to the Act 2 Regional Medicines Inspectorate of Northwestern Switzerland (RFS-NW), Basel, Switzerland Pharmaceuticals for human or veterinary use Fabricating, packaging/labelling, testing Drugs listed in Schedules C and D to the Act 3 Regional Medicines Inspectorate of Eastern and Central Switzerland (RFS-OZ), Zurich, Switzerland Pharmaceuticals for human or veterinary use Fabricating, packaging/labelling, testing Drugs listed in Schedules C and D to the Act 4 Regional Medicines Inspectorate of Southern Switzerland (RFS-S), Ticino, Switzerland Pharmaceuticals for human or veterinary use Fabricating, packaging/labelling, testing Drugs listed in Schedules C and D to the Act 5 Regional Medicines Inspectorate of Western Switzerland (RFS-W), Lausanne, Switzerland Pharmaceuticals for human or veterinary use Fabricating, packaging/labelling, testing Drugs listed in Schedules C and D to the Act
- SOR/97-12, s. 5
- SOR/2000-120, s. 7
- SOR/2002-368, s. 8
- Date modified: